According to Kings Research, the global Milk Protein Hydrolysate Market was estimated at USD 921.2 million in 2023 and is growing at a CAGR of 6.18% through the forecast period ending 2031. Milk protein hydrolysates (MPH) are produced through the controlled enzymatic or acid hydrolysis of whole milk proteins — primarily casein and whey — into shorter peptide chains and amino acids. The resulting ingredients offer superior digestibility, faster absorption, and reduced allergenicity compared to intact proteins, making them highly valued across multiple nutrition segments.

Product Science and Manufacturing

The hydrolysis process involves exposing milk proteins to specific proteolytic enzymes under controlled temperature and pH conditions. The degree of hydrolysis (DH) determines the functional and nutritional profile of the final ingredient — with high DH products offering greater hypoallergenicity and faster absorption, while low DH products retain more functional properties like emulsification and gelation. Manufacturers carefully control DH to match the intended application, whether infant formula, sports nutrition, or medical nutrition products.

Key Application Segments

Infant formula represents the largest and most demanding application for milk protein hydrolysates. Partially hydrolyzed formulas are recommended for infants at risk of cow's milk protein allergy, while extensively hydrolyzed formulas are prescribed for diagnosed allergy cases. Regulatory agencies in the EU, US, and Asia have established strict standards for hydrolysate content in infant formula, driving demand for high-quality, clinically validated ingredients from certified suppliers.

Sports nutrition is the second major growth vector. Athletes require proteins that can be rapidly digested and absorbed to stimulate muscle protein synthesis during the critical post-exercise window. Hydrolyzed whey protein products have demonstrated advantages over intact whey in terms of absorption kinetics, and premium sports nutrition brands increasingly incorporate MPH into recovery shakes, protein bars, and ready-to-drink beverages.

Clinical and medical nutrition represents a specialized but high-value segment. Patients recovering from surgery, those with digestive disorders, and elderly individuals with reduced digestive capacity all benefit from pre-digested protein sources that minimize the metabolic burden of digestion while ensuring adequate amino acid delivery.

Market Drivers

Rising global awareness of protein nutrition, growing prevalence of food allergies, an aging global population, and increasing sports participation are collectively driving MPH demand. The clean-label trend is also influencing product development, as consumers increasingly scrutinize ingredient lists and seek products with recognizable, science-backed ingredients. Milk protein hydrolysates align well with this trend due to their natural dairy origins and well-documented nutritional benefits.

Regional Insights

North America and Europe account for the majority of current MPH consumption, reflecting high per-capita spending on sports nutrition and clinical products, and well-established infant formula markets with regulatory frameworks that support hydrolysate inclusion. Asia-Pacific is the fastest-growing regional market, driven by expanding middle classes, rising infant formula consumption, and growing awareness of sports nutrition in China, India, South Korea, and Australia.

Competitive Dynamics

The MPH market is dominated by major dairy ingredient companies including Arla Foods Ingredients, Fonterra, Glanbia Nutritionals, FrieslandCampina Ingredients, and Kerry Group. These companies invest heavily in hydrolysis technology, quality validation, and regulatory affairs to meet the exacting standards of infant formula customers. Differentiation occurs through clinical substantiation, supply chain transparency, and the ability to provide custom hydrolysis specifications for OEM customers.

Outlook

The Milk Protein Hydrolysate Market is positioned for steady, value-driven growth through 2031. Innovation in hydrolysis technology — including membrane fractionation, bioactive peptide enrichment, and precision fermentation — will create differentiated products with enhanced functional and health-promoting properties. As personalized nutrition becomes more mainstream, demand for tailored MPH formulations matched to individual health profiles and performance goals will create new premium market segments. Kings Research forecasts continued consolidation among ingredient suppliers as scale, regulatory expertise, and clinical investment become increasingly important competitive moats.

Browse To Related-

Salesforce Expands AI Agent Ecosystem in Japan
Eclect and Channel Improve Rakuten Customer Support